We are now very well acquainted with the efficacy of GLP1 receptor agonists (GLP1RAs) in weight management, like semaglutide (Wegovy/Ozempic) and liraglutide (Saxenda), and the dual GLP1/GIP agonist tirzepatide (Zepbound/Mounjaro). What is GLP2 (yes two), and could GLP2 receptor agonism be an untapped frontier in weight management medication?

Learn more: https://drsue.ca/2024/09/could-glp2-receptor-agonists-be-a-new-frontier-in-weight-management-medication/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

Why is type 2 diabetes on the rise in younger people, why does it matter, and what can we do about it? Listen on to find out!

Learn more: https://drsue.ca/2024/09/sounding-the-alarm-the-rising-tide-of-younger-onset-type-2-diabetes/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

Could finerenone (kerendia) be a much-needed addition to the treatment approach in people with HFpEF? Find out here!

Learn more: https://drsue.ca/2024/09/does-finerenone-kerendia-reduce-heart-failure-events-in-people-with-heart-failure-with-preserved-ejection-fraction-hfpef/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

Some doctors and researchers are keen on the idea of inducing diabetes remission with lifestyle changes. A real-life implementation of the DiRECT lifestyle remission protocol was implemented in the UK. Was it successful, and what have we learned? Hint: People don't fail diets. Diets fail people. Read on!

Learn more: https://drsue.ca/2024/09/diabetes-remission-with-lifestyle-intervention-have-we-learned-anything/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

Could women have reproductive concerns related to elevated weight that is NOT PCOS? Introducing FOSH.

Learn more: https://drsue.ca/2024/08/could-women-with-obesity-have-a-cause-of-infrequent-periods-or-fertility-concerns-that-is-not-pcos-introducing-fosh/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

Semaglutide (Ozempic/Wegovy) reduces not only appetite, but also the reward experience of food and possibly even alcohol in our brains. Could it also make people less inclined to smoke?

Learn more: https://drsue.ca/2024/08/could-ozempic-reduce-the-likelihood-of-nicotine-use/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

Metreleptin is a human leptin analog, now approved and available in Canada for treatment of lipodystrophy. Learn more here!

Learn more: https://drsue.ca/2024/08/leptin-analog-for-treatment-of-lipodystrophy-now-available-in-canada/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

Could your statin cholesterol medication cause diabetes? If you have diabetes, how much might your sugars rise with statin therapy?

Learn more: https://drsue.ca/2024/08/could-your-statin-cholesterol-medication-cause-diabetes/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.